
Selwyn
Apple Inc. can import its redesigned Series 9 and Ultra 2 smartwatches after U.S. Customs and Border Protection determined that the new models do not infringe on pulse oximetry patents held by a rival medical device company.
The federal agency decided last week “that Apple’s redesign falls outside the scope of the remedial orders in” the U.S. International Trade Commission’s investigation underlying Apple’s appeal, Knobbe Martens Olson &a...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In